Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? (Q38565570)

4 September 2017

1 reference

title

Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? (English)

1 reference

4 September 2017

Simone Ciufolini

2

0 references

Valeria Mondelli

object named as

Valeria Mondelli

series ordinal

3

0 references

author name string

David Baumeister

series ordinal

1

1 reference

4 September 2017

publication date

14 August 2015

1 reference

4 September 2017

1 reference

4 September 2017

volume

233

1 reference

4 September 2017

issue

9

1 reference

4 September 2017

page(s)

1575-1589

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-015-4044-5

4 September 2017

exact match

0 references

cites work

Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2,3-dioxygenase activation.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1beta administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

A systematic review of the activity of the hypothalamic-pituitary-adrenal axis in first episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Risk and protective factors for depression that adolescents can modify: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Antipsychotic drugs suppress the AKT/NF-κB pathway and regulate the differentiation of T-cell subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

A novel role of the STAT3 pathway in brain inflammation-induced human neural progenitor cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Regulation of macrophage immune responses by antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Reactive nitrogen species in the chemical biology of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Serum and gene expression profile of cytokines in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

A meta-analysis of cytokines in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Cytokines in schizophrenia and the effects of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Insulin-like growth factor-1 abrogates microglial oxidative stress and TNF-α responses to spreading depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

IFN-gamma reduction by tricyclic antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Impact of antipsychotics on cytokine production in-vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Suppressive effect of TRH and antidepressants on human interferon-γ production in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Stimulatory effect of antidepressants on the production of IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

A pilot study evaluating the effect of mindfulness-based stress reduction on psychological status, physical status, salivary cortisol, and interleukin-6 among advanced-stage cancer patients and their caregivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Short and long-term immunosuppressive effects of clozapine and haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

The in vitro immunosuppressive effects of moclobemide in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Inflammatory dietary pattern and risk of depression among women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Calorie restriction dose-dependently abates lipopolysaccharide-induced fever, sickness behavior, and circulating interleukin-6 while increasing corticosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

The role of environmental factors in modulating immune responses in early life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Proinflammatory and "resiliency" proteins in the CSF of patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Cytokine targets in the brain: impact on neurotransmitters and neurocircuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Cytokines in bipolar disorder: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Impact of antidepressants on cytokine production of depressed patients in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Effects of clozapine on plasma cytokine and soluble cytokine receptor levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Neuropsychiatric adverse effects of interferon-alpha: recognition and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

The pro- and anti-inflammatory properties of the cytokine interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

The role of inflammatory cytokines in suicidal behavior: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Quercetin, a phytoestrogen and dietary flavonoid, activates different membrane-bound guanylate cyclase isoforms in LLC-PK1 and PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Effects of antidepressants on IP-10 production in LPS-activated THP-1 human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Early maternal deprivation immunologically primes hippocampal synapses by redistributing interleukin-1 receptor type I in a sex dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

AChE and RACK1 promote the anti-inflammatory properties of fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

First-episode psychosis: an inflammatory state?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Glucocorticoids, cytokines and brain abnormalities in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4044-5

Cytokine production and treatment response in major depressive disorder

21 January 2018

1 reference

12 December 2020

The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers

1 reference

12 December 2020

Inflammation and metabolic changes in first episode psychosis: preliminary results from a longitudinal study

1 reference

12 December 2020

Inflammation: its role in schizophrenia and the potential anti-inflammatory effects of antipsychotics

1 reference

12 December 2020

Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.

1 reference

12 December 2020

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers

1 reference

12 December 2020

Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis

1 reference

12 December 2020

Effects of exercise training on circulating retinol-binding protein 4 and cardiovascular disease risk factors in obese men

1 reference

12 December 2020

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness

1 reference

12 December 2020

Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders.

1 reference

12 December 2020

Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells

1 reference

12 December 2020

Impact of different antipsychotics on cytokines and tryptophan metabolites in stimulated cultures from patients with schizophrenia

1 reference

12 December 2020

Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy

1 reference

12 December 2020

Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania

1 reference

12 December 2020

Neuroleptics modulate cytokine and reactive oxygen species production in blood leukocytes of healthy volunteers

1 reference

12 December 2020

In vitro immunoregulatory effects of antidepressants in healthy volunteers

1 reference

12 December 2020

Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α.

1 reference

12 December 2020

Exposure of foetal neural progenitor cells to IL-1β impairs their proliferation and alters their differentiation - a role for maternal inflammation?

1 reference

12 December 2020

The role of inflammatory cytokines as key modulators of neurogenesis

1 reference

12 December 2020

Lack of a modulatory effect of imipramine on glucocorticoid-induced suppression of interferon-gamma and interleukin-10 production in vitro.

1 reference

12 December 2020

The Interface of Stress and the HPA Axis in Behavioural Phenotypes of Mental Illness

1 reference

12 December 2020

C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia

1 reference

12 December 2020

Paradoxical Anti-Inflammatory Actions of TNF- : Inhibition of IL-12 and IL-23 via TNF Receptor 1 in Macrophages and Dendritic Cells

1 reference

12 December 2020

10.1007/S00213-015-4044-5

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1044236386

0 references

1 reference